Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

A patient produced cortisol after adrenalectomy, possibly due to residual tissue or other body parts making steroids.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Certain supplements, like whey protein isolate and growth hormones, can worsen hair loss.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.